Chlorambucil for the treatment of patients with chronic lymphocytic leukaemia, or small lymphocytic lymphoma
Editorial Group: Cochrane Haematological Malignancies Group
Published Online: 5 OCT 2011
Copyright © 2011 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
How to Cite
Vidal L, Gurion R, Gafter-Gvili A, Raanani P, Robak T, Shpilberg O. Chlorambucil for the treatment of patients with chronic lymphocytic leukaemia, or small lymphocytic lymphoma (Protocol). Cochrane Database of Systematic Reviews 2011, Issue 10. Art. No.: CD009341. DOI: 10.1002/14651858.CD009341.
- Publication Status: New
- Published Online: 5 OCT 2011
This is the protocol for a review and there is no abstract. The objectives are as follows:
To assess the effect of chlorambucil compared to other therapeutic regimens on overall survival, progression free survival, and response rates in patients with CLL/SLL requiring therapy. We will include patients receiving chlorambucil as first-line therapy and patients with relapsed or refractory CLL/SLL receiving salvage therapy with chlorambucil.